May, Arne
Schwedt, Todd J.
Magis, Delphine
Pozo-Rosich, Patricia
Evers, Stefan
Wang, Shuu-Jiun
Article History
First Online: 1 March 2018
Competing interests
: A.M. has been a consultant or speaker for Allergan, Autonomic Technologies, Desitin, Electrocore and Teva and is the Editor in Chief for <i>Cephalalgia</i>. T.J.S. has acted as a consultant or has served on the advisory boards of Allergan, Amgen, Autonomic Technologies, Avanir, Dr. Reddy's, Nocira, Novartis and Teva; has stock options in Nocira and Second Opinion; and has received royalties from UpToDate. D.M. has received research and travel grants from ElectroCore LLC. P.P.-R. has received honoraria as a consultant or speaker from Allergan, Almirall, Chiesi, Eli Lilly, Novartis and Teva. S.E. has received honoraria as a speaker from or is a member of an advisory board for Allergan, Johnson & Johnson, Novartis, Reckitt Benckiser and TAD Pharma. S.-J.W. has served on the advisory boards of Daiichi-Sankyo, Eli Lilly and Taiwan Pfizer and has received honoraria as a moderator from the Taiwan branches of Bayer, Eisai, Eli Lilly and Pfizer.